Ongoing Projects
Coimbra Ophthalmology Reading Centre
Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Retinopathy in Diabetes Type 2 (Protocol nº PTDC/SAU-OSM/72635/2006) [more info]
Retinal Disease Screening System (RDSS) [more info]
Neurodegeneration as an early event in the pathogenesis of Diabetic Retinopathy: A multicentric, prospective, phase II-III, randomised controlled trial to assess the efficacy of neuroprotective drugs administered topically to prevent or arrest Diabetic Retinopathy (EUROCONDOR) (Protocol nº 4C-2011-02) [more info]
Phenotypes of Nonproliferative Diabetic Retinopathy in Diabetes type 2 patients identified by Optical Coherence Tomography, Colour Fundus Photography, Fluorescein Leakage and Multifocal Electrophysiology (DIAMARKER Project: Genetic susceptibility for multi-systemic complications in diabetes type-2: New biomarkers for diagnostic and therapeutic monitoring) (Protocol nº 4C-2011-01) [more info]
Diabetic Retinopathy Screening – Central Region of Portugal [more info]
Identifying progression of retinal disease in eyes with NPDR in diabetes type 2 using non-invasive procedures (Protocol nº ECR-RET-2010-02) [more info]
Prospective, randomized, multicenter, open label phase II study to access efficacy and safety of Lucentis® monotherapy (ranibizumab 0.5 mg intravitreal injections) compared with Lucentis® plus panretinal photocoagulation (PRP) and PRP (monotherapy) in the treatment of patients with high risk proliferative diabetic retinopathy.(Protocol nº CRFB002DPT04T) [more info]
Epidemiological study of the prevalence of age-related macular degeneration in Portugal (Protocol nº CC-01-2009) [more info]